# Registry for Migraine - Structural and Functional MRI Before and After Erenumab Treatment

> **NCT04674020** · PHASE4 · UNKNOWN · sponsor: **Danish Headache Center** · enrollment: 250 (estimated)

## Conditions studied

- Migraine
- Headache

## Interventions

- **DRUG:** Erenumab

## Key facts

- **NCT ID:** NCT04674020
- **Lead sponsor:** Danish Headache Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-22
- **Primary completion:** 2025-07-22
- **Final completion:** 2025-07-22
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2022-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04674020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04674020, "Registry for Migraine - Structural and Functional MRI Before and After Erenumab Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04674020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*